Bracci, Nicolede la Fuente, CynthiaSaleem, SaharPinkham, ChelseaNarayanan, AarthiGarcia-Sastre, AdolfoBalaraman, VelmuruganRicht, Juergen A.Wilson, WilliamKehn-Hall, Kylene2023-05-312023-05-312022-020042-6822http://hdl.handle.net/10919/115268Rift Valley fever virus (RVFV) is an arbovirus that was first reported in the Rift Valley of Kenya which causes significant disease in humans and livestock. RVFV is a tri-segmented, negative-sense RNA virus consisting of a L, M, and S segments with the M segment encoding the glycoproteins Gn and Gc. Host factors that interact with Gn are largely unknown. To this end, two viruses containing an epitope tag (V5) on the Gn protein in position 105 or 229 (V5Gn105 and V5Gn229) were generated using the RVFV MP-12 vaccine strain as a backbone. The V5-tag insertion minimally impacted Gn functionality as measured by replication kinetics, Gn localization, and antibody neutralization assays. A proteomics-based approach was used to identify novel Gn-binding host proteins, including the E3 ubiquitin-protein ligase, UBR4. Depletion of UBR4 resulted in a significant decrease in RVFV titers and a reduction in viral RNA production.application/pdfenPublic Domain (U.S.)Rift valley fever virusGlycoproteinsUBR4GnArticle - Refereedhttps://doi.org/10.1016/j.virol.2021.12.010567350328651089-862X